Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor - Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05510466
What this trial is testing

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06683703
What this trial is testing

Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer Patients with Brain Metastases
Beijing Biostar Pharmaceuticals Co., Ltd. 118
Testing effectiveness (Phase 2)UnknownNCT00276666
What this trial is testing

Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 29
Not applicableLooking for participantsNCT04073966
What this trial is testing

MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets

Who this might be right for
Brain MetastasesNeurocognitive DeficitWhite Matter Alterations+1 more
UNC Lineberger Comprehensive Cancer Center 20
Not applicableUnknownNCT03980431
What this trial is testing

FBY PET/CT in Patients With Brain Tumors

Who this might be right for
Brain Tumor
Peking Union Medical College Hospital 50
Early research (Phase 1)Study completedNCT02808416
What this trial is testing

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

Who this might be right for
Brain CancerNeoplasm Metastases
Guangdong 999 Brain Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT05317858
What this trial is testing

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Who this might be right for
Brain TumorNon Small Cell Lung Cancer
InSightec 30
Not applicableUnknownNCT03721055
What this trial is testing

Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor

Who this might be right for
CancerMetastatic CancerMetastatic Brain Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT04507217
What this trial is testing

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Who this might be right for
NSCLC Stage IVBrain MetastasesPD-1 Antibody
Sun Yat-sen University 36
Not applicableStudy completedNCT03071913
What this trial is testing

Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery

Who this might be right for
Central Nervous System NeoplasmLocalized Brain NeoplasmMetastatic Malignant Neoplasm in the Brain+1 more
Mayo Clinic 54
Large-scale testing (Phase 3)Ended earlyNCT04474925
What this trial is testing

Pre- Versus Post-operative SRS for Resectable Brain Metastases

Who this might be right for
Brain Metastases
AHS Cancer Control Alberta 8
Testing effectiveness (Phase 2)Ended earlyNCT03903640
What this trial is testing

Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis

Who this might be right for
Melanoma With Brain Metastasis
Washington University School of Medicine 2
Testing effectiveness (Phase 2)Study completedNCT06501378
What this trial is testing

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis

Who this might be right for
NSCLC Stage IV
Fudan University 40
Large-scale testing (Phase 3)Study completedNCT02360215
What this trial is testing

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Who this might be right for
Cognitive ImpairmentMetastatic Malignant Neoplasm in the BrainSolid Neoplasm
NRG Oncology 518
Large-scale testing (Phase 3)UnknownNCT05144867
What this trial is testing

Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis

Who this might be right for
Breast CancerBrain Metastases, AdultStereotactic Radiosurgery+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 98
Testing effectiveness (Phase 2)UnknownNCT01763385
What this trial is testing

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

Who this might be right for
Non-small-cell Lung CancerBrain Metastases
Wu Jieping Medical Foundation 210
Large-scale testing (Phase 3)Looking for participantsNCT06159335
What this trial is testing

18F-FLUC PET/MR in Patients With Brain Mets

Who this might be right for
Brain MetastasisRadiation TherapyImmunotherapy, Active
University of Wisconsin, Madison 30
Testing effectiveness (Phase 2)Looking for participantsNCT05045950
What this trial is testing

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Who this might be right for
Brain Metastases
Medical College of Wisconsin 53
Testing effectiveness (Phase 2)Study completedNCT00875433
What this trial is testing

Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours

Who this might be right for
Neoplasms
Boehringer Ingelheim 60
Testing effectiveness (Phase 2)WithdrawnNCT03203616
What this trial is testing

Kadcyla In pAtients With bRAin Metastasis

Who this might be right for
Metastatic HER2-positive Breast Cancer With Brain Metastasis
Jules Bordet Institute
Next Page